Analysts back GSK takeover of Serono

01/30/2006 | Reuters

Industry analysts say a takeover of Serono by GlaxoSmithKline would significantly boost GSK's presence in the area of biological medicines, which GSK was aiming for last year with the creation of its Biopharmaceutical Center of Excellence for Drug Discovery. Also, since both companies are trying to develop multiple sclerosis treatments, the acquisition would give GSK two shots at success in a potentially lucrative business area.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID